Bionomics Limited (BNOX)
USD 0.26
(-4.03%)
USD 0.26
(-4.03%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.68 Million | -14.21 Million | -15.02 Million | -5.65 Million | -2.69 Million | -10.93 Million |
| Net Income | -15.49 Million | -21.21 Million | -15.02 Million | -6.52 Million | -4.91 Million | -7.27 Million |
| Depreciation & Amortization | 662.99 Thousand | 770.6 Thousand | 765.95 Thousand | 1.27 Million | 1.49 Million | 1 Million |
| Deferred income taxes | -139.17 Million | -139.09 Thousand | -139.09 Thousand | -139.81 Thousand | -166.64 Thousand | -170.73 Thousand |
| Stock-based compensation | 814.8 Thousand | 1.9 Million | 2.82 Million | 1.3 Million | 55.35 Thousand | - |
| Change in working capital | 1.45 Million | 33.06 Thousand | -27.02 Thousand | 25.55 Thousand | -159.1 Thousand | -210.35 Thousand |
| Other non-cash items | -2.12 Million | 5.06 Million | -2.55 Million | -1.27 Million | 1 Million | -4.31 Million |
| Investing Cash Flow | - | 319.38 Thousand | 429.23 Thousand | -60.14 Thousand | -134.66 Thousand | 138.76 Thousand |
| Investments in PPE | -4.44 | - | -1066.00 | -1100.78 | -5316.77 | -69.45 Thousand |
| Acquisitions | - | - | 126.97 Thousand | 26.58 Thousand | -498.5 Thousand | 9962.08 |
| Investment purchases | - | - | -442.89 Thousand | -88.36 Thousand | -34.97 Thousand | - |
| Sales/Maturities of investments | - | - | 315.92 Thousand | 61.78 Thousand | 368.7 Thousand | - |
| Other Investing Activities | - | 319.38 Thousand | 430.3 Thousand | -59.04 Thousand | 35.42 Thousand | 198.25 Thousand |
| Financing Cash Flow | 15.1 Million | 3.7 Million | 18.63 Million | 23.66 Million | -3.69 Million | 3.05 Million |
| Debt repayment | - | -106.59 Thousand | -120.28 Thousand | -8.89 Million | -5.71 Million | -3.74 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -415.47 Thousand | -48.22 Thousand | -420.36 Thousand |
| Common Stock Issuance | 10.11 Million | 3.84 Million | 19.7 Million | 32.38 Million | 1.96 Million | 6.92 Million |
| Other Financing Activities | 4.99 Million | 3.7 Million | 18.63 Million | 23.66 Million | -3.69 Million | 3.05 Million |
| Accounts receivables | 299.2 Thousand | 33.06 Thousand | -27.02 Thousand | 25.55 Thousand | -139.58 Thousand | -103.41 Thousand |
| Accounts payables | 804.37 Thousand | 480.4 Thousand | 710.61 Thousand | -47.22 Thousand | 85.43 Thousand | -1.01 Million |
| Inventory | - | -4.79 Million | 3.89 Million | 152.82 Thousand | -19.52 Thousand | -106.93 Thousand |
| Other working capital | 351.28 Thousand | 4.31 Million | -4.6 Million | -105.6 Thousand | -85.43 Thousand | 1.01 Million |
| Cash at beginning of period | 12.18 Million | 23.17 Million | 21.37 Million | 3.15 Million | 9.81 Million | 18.45 Million |
| Cash at end of period | 12.68 Million | 12.15 Million | 23.17 Million | 21.37 Million | 3.15 Million | 9.81 Million |
| Capital Expenditure | -4.44 | - | -1066.00 | -1100.78 | -5316.77 | -69.45 Thousand |
| Effect of forex changes on cash | 76.97 Thousand | -5078.59 | -549.86 Thousand | -9803.54 | 32.85 Thousand | 61.27 Thousand |
| Net cash flow / Change in cash | 504.99 Thousand | -11.01 Million | 1.8 Million | 18.21 Million | -6.65 Million | -8.63 Million |
| Free Cash Flow | -14.68 Million | -14.21 Million | -15.02 Million | -5.65 Million | -2.69 Million | -11 Million |
| Breakdown | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -81.41 Thousand | -5.23 Million | -4.93 Million | -10.41 Million | -21.21 Million | -5.22 Million |
| Depreciation & Amortization | 436.34 Thousand | - | - | 770.6 Thousand | 770.6 Thousand | 386.74 Thousand |
| Deferred income taxes | - | - | - | -139.69 Thousand | -139.09 Thousand | - |
| Stock-based compensation | - | - | - | 634.25 Thousand | 1.9 Million | 636.63 Thousand |
| Change in working capital | - | - | - | 33.06 Thousand | 33.06 Thousand | 2.15 Million |
| Other non-cash items | -821.89 Thousand | 361.81 Thousand | 341.25 Thousand | 268.49 Thousand | 5.06 Million | -2.07 Million |
| Investing Cash Flow | - | 72.86 Thousand | 68.72 Thousand | 192.1 Thousand | 319.38 Thousand | 96.41 Thousand |
| Investments in PPE | 3.73 | 2.05 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 72.86 Thousand | 68.72 Thousand | 192.1 Thousand | 319.38 Thousand | 96.41 Thousand |
| Financing Cash Flow | 2.71 Million | 3.77 Million | 3.56 Million | -264.78 Thousand | 3.7 Million | -306 Thousand |
| Debt repayment | -745 Thousand | -745 Thousand | - | -40.96 Thousand | -106.59 Thousand | -40 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.4 Million | 6.53 Million | - | -179.22 Thousand | 3.84 Million | - |
| Other Financing Activities | 55.31 Thousand | 3.77 Million | 3.56 Million | -264.78 Thousand | 3.7 Million | -266 Thousand |
| Accounts receivables | - | - | - | 33.06 Thousand | 33.06 Thousand | 16.59 Thousand |
| Accounts payables | - | - | - | - | 480.4 Thousand | - |
| Inventory | - | - | - | - | -4.79 Million | - |
| Other working capital | - | - | - | 2.13 Million | 4.31 Million | 2.14 Million |
| Cash at beginning of period | 10.14 Million | 12.14 Million | - | 20.89 Million | 23.17 Million | 30.69 Million |
| Cash at end of period | 8.42 Million | -1.15 Million | -1.08 Million | 12.14 Million | 12.15 Million | 22.44 Million |
| Capital Expenditure | 3.73 | 2.05 | - | - | - | - |
| Effect of forex changes on cash | - | -125.45 Thousand | -118.32 Thousand | -3033.17 | -5078.59 | -1000.00 |
| Net cash flow / Change in cash | -1.72 Million | -13.3 Million | -1.08 Million | -8.75 Million | -11.01 Million | -8.25 Million |
| Free Cash Flow | -466.95 Thousand | -4.87 Million | -4.59 Million | -8.21 Million | -14.21 Million | -4.12 Million |
SUYOG
APGE
ADOC
MAKSY
MOB
6678